Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OracleBio is a private contract research organization focused on quantitative digital pathology for pharmaceutical and biotechnology R&D. The company provides fee-for-service image analysis, histopathology quantification, translational biomarker support, and clinical tissue analysis across preclinical, translational, and clinical studies. OracleBio is particularly known for multiplex tissue analysis, cellular phenotyping, and AI-enabled image analysis workflows used to support biomarker discovery and drug development. Its service offerings span immuno-oncology, NASH and fibrosis, and broader tissue-based research applications rather than an internal therapeutic drug pipeline. The company operates as a specialized CRO serving global pharma and biotech clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OracleBio.